Security key
457637502
InMed Pharmaceuticals Inc. - Common Stock (INM)
CUSIP: 457637502
Q1 2022 13F Holders as of 31 Mar 2022
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 359,540
- Total 13F value
- $339,482
- Share change
- -45,639
- SEC-reported price per share
- $0.94
- Number of holders
- 11
- Value change
- -$46,245
- Number of buys
- 5
- Number of sells
- 3
- Shares outstanding
- 737,449
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2022
Institutions
11
Top holders
10
INM full security history
Ownership snapshot
Full 13F holder table
InMed Pharmaceuticals Inc. SEC filings
InMed Pharmaceuticals Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of INM - InMed Pharmaceuticals Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
TWO SIGMA ADVISERS, LP
Disclosed value leader
TWO SIGMA ADVISERS, LP
Comparable rows
11/15
Latest evidence
24 Jan 2022
13F
3/4/5
Lead comparable stake: 28%
4 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
TWO SIGMA ADVISERS, LP leads the comparable SEC ownership view at 28%.
11 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens TWO SIGMA ADVISERS, LP's linked filing trail.
Comparable ownership
Top 5
TWO SIGMA ADVISERS, LP
28%
TWO SIGMA INVESTMENTS, LP
18%
RENAISSANCE TECHNOLOGIES LLC
6%
CITADEL ADVISORS LLC
1.5%
Creative Planning
1.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| TWO SIGMA ADVISERS, LP |
13F
Company
|
28%
|
$270,000
205,800 shares
|
— | 31 Dec 2021 |
| TWO SIGMA INVESTMENTS, LP |
13F
Company
|
18%
|
$172,000
131,673 shares
|
— | 31 Dec 2021 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
6%
|
$58,000
44,200 shares
|
— | 31 Dec 2021 |
| CITADEL ADVISORS LLC |
13F
Company
|
1.5%
|
$14,000
11,060 shares
|
— | 31 Dec 2021 |
| Creative Planning |
13F
Company
|
1.5%
|
$14,000
10,832 shares
|
— | 31 Dec 2021 |
| TD Waterhouse Canada Inc. |
13F
Company
|
0.29%
|
$3,683
2,130 shares
|
— | 31 Dec 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
11
Shares
359,540
Rows available
11
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2022 vs Q1 2022 Across Filers
Q1 2022 holders
11
Q1 2022 holders
11
Holder diff
0
| Investor | Q1 2022 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q1 2022 value | Value change | Value Chg % |
|---|